Filing Flows

Filing Flows › Fresenius Medical Care AG (FMS) › How it makes money

How Fresenius Medical Care AG (FMS) makes money

Fresenius Medical Care AG (FMS) made $9.9B of revenue in the third quarter 2026 (Q3 2026), +1% from a year earlier. 2 a), 14 brought in $4.9B (50%); Healthcare services brought in $3.3B (34%); Healthcare products brought in $1.1B (11%). Of every dollar of revenue, 4¢ was left as operating profit, 2¢ was left as net earnings.

Drawing the Sankey…

Fresenius Medical Care AG revenue by segment, Q3 2026Fresenius Medical Care AG revenue by segment, Q3 20262 a), 14$4.9BHealthcare services$3.3BHealthcare products$1.1BInsurance contracts$504M
Fresenius Medical Care AG: where each dollar of revenue goesFresenius Medical Care AG: where each dollar of revenue goesOperating profit4¢Income tax1¢Net earnings2¢

Revenue by segment, Q3 2026

SegmentRevenueShareQ/QY/Y
2 a), 14$4.9B50.0%—+1%
Healthcare services$3.3B33.6%—+3%
Healthcare products$1.1B11.3%—+2%
Insurance contracts$504M5.1%—-11%

Where each dollar of revenue goes

LineQ3 2026% of revenue
Revenue$9.9B100.0%
Operating profit$384M3.9%
Income tax$77.8M0.8%
Net earnings$160M1.6%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q3 2026$9.9B+1%

From Fresenius Medical Care AG's 6-K filed Nov 3, 2026 (on EDGAR).

Questions

How does Fresenius Medical Care AG make money?

Fresenius Medical Care AG (FMS) made $9.9B of revenue in the third quarter 2026 (Q3 2026), +1% from a year earlier. 2 a), 14 brought in $4.9B (50%); Healthcare services brought in $3.3B (34%); Healthcare products brought in $1.1B (11%). Of every dollar of revenue, 4¢ was left as operating profit, 2¢ was left as net earnings.

What is Fresenius Medical Care AG's biggest business?

2 a), 14: $4.9B in the third quarter 2026, 50% of revenue, +1% from a year earlier.

What is Fresenius Medical Care AG's profit margin?

Net earnings were $160M, 1.6% of revenue, in the third quarter 2026; the operating margin was 3.9%.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.